Stay updated on Nivolumab + Low Dose Radiotherapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Low Dose Radiotherapy Clinical Trial page.

Latest updates to the Nivolumab + Low Dose Radiotherapy Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section with Pennsylvania as a location and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure and Pennsylvania Locations entries (reflecting the previous version v3.3.2).SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new revision tag v3.3.2 replacing v3.2.0. Core study information and navigation remain unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedDeleted a temporary government funding status notice that did not affect the study details, eligibility criteria, or results information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedResults for the study have been posted and related sections updated to reflect the new data.SummaryDifference0.5%

- Check82 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0. If any other changes were intended, they are not present.SummaryDifference5%

- Check89 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Low Dose Radiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Low Dose Radiotherapy Clinical Trial page.